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cellular roles of dnA Polymerase Beta 
Sreerupa Ray, Miriam Rose Menezes, Alireza Senejani, and Joann
B. Sweasy*
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut
Since its discovery and purification in 1971, DNA polymerase ß (Pol ß†) is one of the most
well-studied DNA polymerases. Pol ß is a key enzyme in the base excision repair (BER)
pathway that functions in gap filling DNA synthesis subsequent to the excision of damaged
DNA bases. A major focus of our studies is on the cellular roles of Pol ß. We have shown
that germline and tumor-associated variants of Pol ß catalyze aberrant BER that leads to ge-
nomic instability and cellular transformation. Our studies suggest that Pol ß is critical for the
maintenance of genomic stability and that it is a tumor suppressor. We have also shown
that Pol ß functions during Prophase i of meiosis. Pol ß localizes to the synaptonemal com-
plex and is critical for removal of the Spo11 complex from the 5’ ends of double-strand
breaks. Studies with Pol ß mutant mice are currently being undertaken to more clearly un-
derstand the function of Pol ß during meiosis. in this review, we will highlight our contribu-
tions from our studies of Pol ß germline and cancer-associated variants.
introduction
DNA polymerase beta (Pol ß) was
originally purified from rabbit bone mar-
row by Chang and Bollum and character-
ized as a low molecular weight DNA
polymerase [1]. Several years later, Abbotts
and Wilson subcloned the cDNA of both
human and rat Pol ß and successfully ex-
pressed this protein in Escherichia coli [2],
permitting large quantities of active en-
zyme to be purified and studied.
Pol ß is a 39 kDa protein with DNA
polymerase and deoxyribose phosphatase
(dRP lyase) activities [2-4]. It belongs to
the X family of DNA polymerases. DNA
polymerase β is expressed in all stages of
the cell cycle and in all of the analyzed tis-
sues [5,6]. Since the time of its cloning and
purification, Pol ß has become one of the
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most highly studied DNA polymerases. In
this overview, we will discuss our contribu-
tions to elucidating the mechanism of DNA
synthesis of Pol ß with particular regard to
variants of this enzyme identified in the
germlines of humans in tumors.
Joann Sweasy (JS) performed her grad-
uate work with Evelyn Witkin on the roles of
E. coli recA mutants in SOS mutagenesis
and the restart of DNA synthesis cultivated
an interest in the study of DNA polymerases
[7-9]. This led her to join Lawrence Loeb’s
laboratory, where she began research on Pol
ß. To understand the mechanisms of sub-
strate choice by Pol ß, JS set out to charac-
terize mutator variants of Pol ß.
Identification of mutator variants in human
or mouse cells would be difficult, so, draw-
ing upon her previous experience as a grad-
uate student, she decided to develop a
complementation system in E. coli, and,
using the Pol ß cDNA clone generously
given to the laboratory by Dr. Samuel Wil-
son, showed that rat Pol ß could substitute
for E. coli Pol I in the joining of Okazaki
fragments during DNA replication [10]. This
permitted JS to use E. coli mutation re-
porters to identify Pol ß mutator mutants
[11]. JS carried a box full of Pol ß mutator
variants [12] with her to her new faculty po-
sition in the Department of Therapeutic Ra-
diology at Yale School of Medicine, a
department with an incredible history of re-
search in DNA repair that she was very en-
thusiastic to join. Since that time, JS’s
laboratory has characterized many of these
mutator variants of Pol ß, showing how
amino acid residues of Pol ß distant from the
active site are critical for accurate DNA syn-
thesis. In addition to this work, JS became
interested in understanding the cellular roles
of Pol ß and initiated work in this area using
polymorphic and cancer-associated variants
of Pol ß, and this is the focus of this
overview. 
Pol ß And BAse excision rePAir
Pol ß functions in base excision repair
(BER), a major genome maintenance path-
way in mammalian cells that is responsible
for removal and repair of at least 20,000
DNA lesions per cell per day [13]. The sim-
plest and most common form of BER is
short patch BER, which can be initiated by
one of several different DNA glycosylases,
each having preferences for specific types of
lesions [14]. Monofunctional DNA glycosy-
lases recognize DNA lesions and catalyze
the hydrolysis of the N-glycosylic bond to
generate an abasic site. The abasic site is
nicked at its 5’ side by the APE1 endonucle-
ase, leaving a 3’OH and a 5’deoxyribose
phosphate (dRP). Pol ß fills in the single nu-
cleotide gap and catalyzes removal of the
dRP group. Bifunctional glycosylases,
which usually recognize oxidative lesions,
generate an abasic site and then catalyze its
removal via ß-elimination to generate a
3’dRP and 5’phosphate. APE1 then removes
the 3’dRP, leaving a 3’OH, to which Pol ß
can bind and fill in the resulting single nu-
cleotide gap. In both cases, the XRCC1/Lig-
ase IIIα or XRCC1/Ligase I complex
catalyzes ligation of the resulting ends. An
alternative BER pathway that does not de-
pend on APE1 is utilized when the NEIL
glycosylases initiate repair [15]. NEIL 1, 2,
and perhaps 3 catalyze excision of the dam-
aged base via ß,δ elimination, leaving a
3’phosphate and a 5’phosphate. The 3’phos-
phate is removed by polynucleotide kinase,
leaving a gap that is most often filled by Pol
ß, followed by ligation. Therefore, Pol ß is
required for all forms of BER.
Germline VAriAnts of Pol ß
Five hundred sixty-seven SNPs have
been identified in the 33 Mb POLB gene, of
which only 22 are found within the coding
region [16,17]. Two missense germline vari-
ants of Pol β have been identified in the
human population. These are R137Q
(rs12678588) and P242R (rs3136797),
which have been reported to be present in 0.6
percent and 2.4 percent, respectively, of the
human population [18]. The P242R variant
was specifically identified in Keralites and
Europeans. The R137Q Pol ß variant has re-
duced polymerase activity and an impaired
interaction with PCNA. When expressed in
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Pol β-deficient MEFs, R137Q confers sensi-
tivity to the DNA damaging agents methyl
methanesulfonate (MMS) and N-methyl-N-
nitrosourea (MNU) [19]. Pol β P242R also
catalyzes DNA synthesis with a reduced rate
[20]. In human mammary epithelial cells,
P242R Pol β induces chromosomal aberra-
tions and cellular transformation, suggesting
a putative role for P242R Pol β as a cancer
driver [20]. The mechanistic basis underly-
ing the generation of chromosomal aberra-
tions is the slow BER gap filling catalyzed
by P242R. Unfilled gaps in the proximity of
the replication fork lead to the induction of
double-strand breaks and can result in chro-
mosomal aberrations, as shown in Figure 1.
The studies on Pol β R137Q and P242R sug-
gest that individuals with these variants have
an increased risk of developing cancer. This
hypothesis is currently being tested using
mouse models. 
tumor-AssociAted Pol ß VAriAnts
Small-scale sequencing studies have re-
vealed that POL B is mutated in 30 percent
to 40 percent of human tumors, including
colon, gastric, and prostate carcinomas
[21,22]. Interestingly, the resulting amino
acid alterations are not localized to one par-
ticular domain of Pol β but are widespread
across the protein [22].
Colon Tumor-Associated Pol ß Variants
The K289M Pol ß variant was identified
in a colon carcinoma [23]. We showed that
K289M is a sequence context-dependent
mutator in mouse cells and that it induced
mutations at a 16-fold greater frequency
within a sequence nearly identical to a highly
mutated sequence in the APC gene, the mu-
tation of which results in colon cancer [24].
Work from our laboratory also demonstrated
that expression of K289M in immortal but
non-transformed mouse cells induces cellu-
lar transformation through a mutational
process as shown in Figure 1 [25]. 
Given this result, our laboratory se-
quenced the exons 5’ and 3’ UTRs of the
POL B gene from colon tumors and found
that 40 percent of these tumors carried a mu-
tation in the coding region of POL B that
was not found in normal tissue [22]. A sub-
set of these variants that were predicted by
mathematical algorithms to be damaging ex-
hibited reduced DNA polymerase activity.
465Ray et al.: Cellular roles of DNA polymerase beta
figure 1. mechanisms of genomic instability generated by Pol ß variant proteins.
The DNA substrate for Pol ß is usually a single nucleotide gap with a 5’dRP group (red)
that is generated upon excision of a damaged base. A mutator variant of Pol ß will remove
the dRp group using its dRp lyase activity and fill in the gap in an error-prone manner, in-
ducing mutations (denoted by X). A Pol ß variant with slow polymerase activity (low activity
variant) will remove the dRp group, but not fill in all gaps in the cell, leading to the accu-
mulation of BER intermediates and eventually to genomic instability. Failure to remove the
dRp group by a Pol ß variant with slow dRp lyase activity will also result in the accumula-
tion of BER intermediates and genomic instability.
We showed that two of these variants,
G231D and E295K, which was also identi-
fied in a gastric carcinoma [26], induce
chromosomal aberrations and cellular trans-
formation [27,28]. The G231D variant has a
low affinity for the incoming nucleotide due
to a disordered active site once bound to
DNA [27]. E295K appears to lack DNA
polymerase activity as a result of its inabil-
ity to assume an active polymerase confor-
mation [28,29]. During BER, neither of
these variants fills single nucleotide gaps in
an efficient manner, leading to the accumu-
lation of BER intermediates and resulting in
an increase in double-strand breaks and ge-
nomic instability (Figure 1). The E288K
variant was also identified in a colon carci-
noma [22]. Interestingly, this variant is a se-
quence context-dependent mutator and
prefers to misincorporate nucleotides oppo-
site template A, which could result in a mu-
tator phenotype in human cells [30].
Gastric Carcinoma-Associated Pol ß
Variants
In addition to E295K, Pol β L22P,
Y265C, and D160N were identified in
human gastric carcinomas [26]. L22P has
low affinity for DNA and very low dRP
lyase activity [31]. The expression of L22P
in Pol β deficient mouse embryo fibroblasts
(MEFs) results in sensitivity to MMS and
cellular transformation in immortalized
mouse cells, likely as a result of the accu-
mulation of BER intermediates [31]. Y265C
catalyzes DNA synthesis at a significantly
slower rate than WT Pol ß and is also a mu-
tator polymerase [11,32,33]. In mouse LN12
cells, expression of Y265C leads to an 8-fold
increase in mutation frequency, and the
types of mutations induced include point
mutations and small deletions [32]. Y265C
has normal dRP lyase activity [34]. We re-
cently constructed the Y265C Pol β knock-
in mouse model [34]. The homozygous
mutant animals are born at the expected
Mendelian ratio; however, they are small
and 60 percent die within a few hours post
birth. The POL B Y265c/c E11 and E14 em-
bryos and newborn mice are 33 percent
smaller (p < 0.0001) than their wild-type and
heterozygous littermates [34]. We showed
that MEFs isolated from these mice exhibit
slow proliferation. Significantly higher lev-
els of apoptosis were observed in the POL B
Y265c/c MEFs versus MEFs from wild-type
mice. In combination, these results indicate
that both slow proliferation and increased
cell death contribute to the small size of the
c/c mice [34]. We showed that BER inter-
mediate substrates accumulate in the POL B
Y265c/c MEFs in the form of unfilled gaps and
that these substrates resulted in increased
levels of chromosomal aberrations. The
D160N variant, also identified in a gastric
carcinoma, induces complex tandem muta-
tions that appear to be template-dependent
[35]. We suggest that the active site of this
variant exists in a conformation that can ac-
commodate movement of the DNA sub-
strate, permitting complex mutations to be
generated.
Prostate Cancer-Associated Pol ß Variant
The I260M prostate cancer-associated
variant is a sequence context-dependent base
substitution mutator [36] that also induces in-
sertions of dinucleotide repeats within runs
of the same types of repeats. Expression of
I260M in immortal but non-transformed
mouse epithelial cells results in cellular
transformation by a mutational mechanism
[25] (Figure 1, mutator phenotype).
In summary, Pol ß variants have the po-
tential to drive cancer by induction of a mu-
tator phenotype or genomic instability, as
shown in Figure 1. Our results suggest that
during the gap filling step of BER, which
occurs at least 20,000 times per cell per day,
some of the Pol ß variants, including I260M,
insert the incorrect nucleotide, eventually re-
sulting in a mutation. Should the mutation
occur within key growth control genes, it
could lead to cancer. For example, we
showed that expression of I260M in mouse
epithelial cells led to mutation of PPARγ, re-
sulting in global alterations in gene expres-
sion [37]. Interestingly, PPARγ has been
suggested to function as a tumor suppressor.
In contrast, many of the Pol ß variants fill
single nucleotide gaps less efficiently than
WT Pol ß, leading to accumulation of BER
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intermediates that result in chromosomal
aberrations and cellular transformation.
BER is a highly coordinated process, and
our results suggest that imbalances in this re-
pair pathway have the potential to lead to
cancer. In combination, our results suggest
that Pol β is critical for the repair of en-
dogenous DNA damage and the mainte-
nance of genomic stability.
role of dnA PolymerAse β in
meiosis
Meiosis involves a highly orchestrated
process of cell division wherein diploid cells
undergo two successive divisions to produce
four haploid germ cells. Meiotic recombina-
tion involves physical interaction between
homologous chromosomes, which form chi-
asmata and lead to crossover products [38].
The meiotic recombination pathway is in-
duced by formation of DNA double strand
breaks (DSBs) by the meiosis-specific
Spo11 complex, a relative of archeal topoi-
somerase VI [39], during the leptotene sub-
stage of Prophase I [40]. DSBs are marked
by formation of γH2AX foci, a phosphory-
lated version of H2A. DSBs are repaired
through the pachytene substage of Prophase
I in processes resulting in crossover and
non-crossover products [39]. Synapsis oc-
curs between chromosomes and genetic ex-
change is facilitated by synaptonemal
complex (SC) formation. Upon introduction
of DSBs, Rad51, a RecA homolog in eu-
karyotes promotes homology search and
DNA strand invasion. Dmc1, a meiosis-spe-
cific protein, also promotes homology-di-
rected DNA strand exchange that leads to
crossover products. The homologs synapse
in the zygotene substage of Prophase I [41].
During the diplotene substage, the homologs
desynapse and crossovers are formed which
are an essential outcome of meiotic recom-
bination [41]. The crossovers are observed
as chiasmata [42,43]. The enzymes involved
in the catalysis of DNA synthesis during
meiosis are not well characterized.
DNA polymerases are known to function
in DNA replication, repair, and recombina-
tion. Interestingly, expression of DNA Pol β
is highest in mouse testis, suggesting that it
may have a role in meiosis [44]. Recently it
has also been shown that overexpression of
Pol β stimulates Rad51-dependent homolo-
gous recombination in mammalian cells [45].  
We initiated our studies of Pol ß in
meiosis in collaboration with Terry Ashley
and attempted to localize Pol ß to the SC.
We showed that Pol ß foci were present on
the SC during Prophase I of meiosis in a pat-
tern consistent with the idea that this enzyme
functions in DSB repair during this process
[44]. Deletion of the POL B gene in mice
leads to lethality, thus to characterize the
role of Pol β in meiosis, we employed the
Cre-loxP gene targeting system to delete the
POL B gene specifically in primordial germ
cells. Synapsis is defective in spermatocytes
and oocytes isolated from these mice. Im-
portantly, Pol β-deficient spermatocytes
have persistent Spo11-induced γH2AX
DSBs and a significantly reduced level of
Spo11-complex removal from the 5’ end of
the DSB. Thus Pol β has a very critical role
in meiosis that is associated with the re-
moval of the Spo 11 complex [41]. We sug-
gest that Pol ß can act as a “landing
platform” for other proteins that are required
for Spo 11 removal. Alternatively, Pol ß
could facilitate formation of a DNA struc-
ture, which is conducive to removal of
Spo11. Additional experiments are being
conducted to more clearly define the role of
the Pol ß protein in Prophase I of meiosis.
conclusions And outlook
Experiments from our laboratory have
shown that Pol ß functions in DNA repair
and during Prophase I of meiosis. Pol ß
functions to maintain genomic stability dur-
ing DNA BER. Both germline and cancer-
associated variants lead to aberrant DNA
repair that is either error-prone or inefficient,
resulting in the accumulation of BER inter-
mediates. Therefore, Pol ß somatic and
germline variants have the potential to be
cancer drivers and to impact cancer therapy.
We have also shown that Pol ß functions
during Prophase I of meiosis, although its
precise role during this process is not
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known. This has led us to characterize meio-
sis in mice that express various Pol ß vari-
ants and these experiments are currently
under way. 
Acknowledgment: This work was supported
by CA 116753, ES019179, and CA 080830
to JBS.
references
1. Chang LM, Bollum FJ. Low molecular
weight deoxyribonucleic acid polymerase
from rabbit bone marrow. Biochemistry.
1972;11(7):1264-72. 
2. Abbotts J, SenGupta DN, Zmudzka B, Widen
SG, Notario V, Wilson SH. Expression of
human DNA polymerase beta in Escherichia
coli and characterization of the recombinant
enzyme. Biochemistry. 1988;27(3):901-9. 
3. Matsumoto Y, Kim K. Excision of deoxyri-
bose phosphate residues by DNA polymerase
beta during DNA repair. Science.
1995;269(5224):699-702. 
4. Matsumoto Y, Kim K, Katz DS, Feng JA.
Catalytic center of DNA polymerase beta for
excision of deoxyribose phosphate groups.
Biochemistry. 1998;37(18):6456-64. 
5. Hirose F, Hotta Y, Yamaguchi M, Matsukage
A. Difference in the expression level of DNA
polymerase beta among mouse tissues: high
expression in the pachytene spermatocyte.
Exp Cell Res. 1989;181(1):169-80. 
6. Zmudzka BZ, Fornace A, Collins J, Wilson
SH. Characterization of DNA polymerase
beta mRNA: cell-cycle and growth response
in cultured human cells. Nucleic Acids Res.
1988;16(20):9587-96. 
7. Sweasy JB, Witkin EM. Novel SOS pheno-
types caused by second-site mutations in the
recA430 gene of Escherichia coli. Biochimie.
1991;73(4):437-48. 
8. Sweasy JB, Witkin EM, Sinha N, Roegner-
Maniscalco V. RecA protein of Escherichia
coli has a third essential role in SOS mutator
activity. J Bacteriol. 1990;172(6):3030-6. 
9. Witkin EM, Roegner-Maniscalco V, Sweasy
JB, McCall JO. Recovery from ultraviolet
light-induced inhibition of DNA synthesis re-
quires umuDC gene products in recA718 mu-
tant strains but not in recA+ strains of
Escherichia coli. Proc Natl Acad Sci USA.
1987;84(19):6805-9. 
10. Sweasy JB, Loeb LA. Mammalian DNA poly-
merase beta can substitute for DNA polymerase
I during DNA replication in Escherichia coli. J
Biol Chem. 1992;267(3):1407-10.
11. Washington SL, Yoon MS, Chagovetz AM,
Li SX, Clairmont CA, Preston BD, et al. A
genetic system to identify DNA polymerase
beta mutator mutants. Proc Natl Acad Sci
USA. 1997;94(4):1321-6. 
12. Sweasy JB, Loeb LA. Detection and charac-
terization of mammalian DNA polymerase
beta mutants by functional complementation
in Escherichia coli. Proc Natl Acad Sci USA.
1993;90(10):4626-30. 
13. Barnes DE, Lindahl T. Repair and genetic
consequences of endogenous DNA base dam-
age in mammalian cells. Annu Rev Genet.
2004;38:445-76. 
14. Freidberg EC, Wood RD, Walker GC, Siede
W. DNA Repair and Mutagenesis. Second
edition. Washington, DC: ASM Press; 2006.
15. Wiederhold L, Leppard JB, Kedar P, Karimi-
Busheri F, Rasouli-Nia A, Weinfeld M, et al.
AP endonuclease-independent DNA base ex-
cision repair in human cells. Mol Cell.
2004;15(2):209-20. 
16. Nemec AA, Wallace SS, Sweasy JB. Variant
base excision repair proteins: contributors to
genomic instability. Semin Cancer Biol.
2010;20(5):320-8. 
17. Sobol RW, Wilson SH. Mammalian DNA
beta-polymerase in base excision repair of
alkylation damage. Prog Nucleic Acid Res
Mol Biol. 2001;68:57-74. 
18. Yamtich J, Speed WC, Straka E, Kidd JR,
Sweasy JB, Kidd KK. Population-specific
variation in haplotype composition and het-
erozygosity at the POLB locus. DNA Repair
(Amst). 2009;8(5):579-84. 
19. Guo Z, Zheng L, Dai H, Zhou M, Xu H, Shen
B. Human DNA polymerase beta polymor-
phism, Arg137Gln, impairs its polymerase
activity and interaction with PCNA and the
cellular base excision repair capacity. Nucleic
Acids Res. 2009;37(10):3431-41. 
20. Yamtich J, Nemec AA, Keh A, Sweasy JB. A
germline polymorphism of DNA polymerase beta
induces genomic instability and cellular transfor-
mation. PLoS Genet. 2012;8(11):e1003052. 
21. Starcevic D, Dalal S, Sweasy JB. Is there a
link between DNA polymerase beta and can-
cer? Cell Cycle. 2004;3(8):998-1001. 
22. Donigan KA, Sun KW, Nemec AA, Murphy
DL, Cong X, Northrup V, et al. Human POLB
gene is mutated in high percentage of colorec-
tal tumors. J Biol Chem. 2012;287(28):23830-
9. 
23. Wang L, Patel U, Ghosh L, Banerjee S. DNA
polymerase beta mutations in human colorec-
tal cancer. Cancer Res. 1992;52(17):4824-7. 
24. Lang T, Maitra M, Starcevic D, Li S-X,
Sweasy JB. A DNA polymerase beta mutant
from colon cancer cells induces mutations.
Proc Natl Acad Sci USA. 2004;101(16):6074-
9. 
25. Sweasy JB, Lang T, Starcevic D, Sun KW, Lai
CC, Dimaio D, et al. Expression of DNA poly-
merase {beta} cancer-associated variants in
mouse cells results in cellular transformation.
Proc Natl Acad Sci USA. 2005;102(40):14350-
5.
26. Iwanaga A, Ouchida M, Miyazaki K, Hori K,
Mukai T. Functional mutation of DNA poly-
merase beta found in human gastric cancer--
inability of the base excision repair in vitro.
Mutat Res. 1999;435(2):121-8. 
468 Ray et al.: Cellular roles of DNA polymerase beta
27. Nemec AA, Donigan KA, Murphy DL,
Jaeger J, Sweasy JB. Colon cancer-associated
DNA polymerase beta variant induces ge-
nomic instability and cellular transformation.
J Biol Chem. 2012;287(28):23840-9. 
28. Lang T, Dalal S, Chikova A, DiMaio D,
Sweasy JB. The E295K DNA polymerase
beta gastric cancer-associated variant inter-
feres with base excision repair and induces
cellular transformation. Mol Cell Biol.
2007;27(15):5587-96. 
29. Li Y, Gridley CL, Jaeger J, Sweasy JB,
Schlick T. Unfavorable electrostatic and steric
interactions in DNA polymerase beta E295K
mutant interfere with the enzyme’s pathway. J
Am Chem Soc. 2012;134(24):9999-10010. 
30. Murphy DL, Donigan KA, Jaeger J, Sweasy
JB. The E288K colon tumor variant of DNA
polymerase beta is a sequence specific muta-
tor. Biochemistry. 2012;51(26):5269-75. 
31. Dalal S, Chikova A, Jaeger J, Sweasy JB. The
Leu22Pro tumor-associated variant of DNA
polymerase beta is dRP lyase deficient. Nu-
cleic Acids Res. 2008;36(2):411-22. 
32. Clairmont CA, Narayanan L, Sun KW, Glazer
PM, Sweasy JB. The Tyr-265-to-Cys mutator
mutant of DNA polymerase beta induces a
mutator phenotype in mouse LN12 cells. Proc
Natl Acad Sci USA. 1999;96(17):9580-5. 
33. Opresko PL, Sweasy JB, Eckert KA. The mu-
tator form of polymerase beta with amino
acid substitution at tyrosine 265 in the hinge
region displays an increase in both base sub-
stitution and frame shift errors. Biochemistry.
1998;37(8):2111-9. 
34. Senejani AG, Dalal S, Liu Y, Nottoli TP, Mc-
Grath JM, Clairmont CS, et al. Y265C DNA
polymerase beta knockin mice survive past
birth and accumulate base excision repair in-
termediate substrates. Proc Natl Acad Sci
USA. 2012;109(17):6632-7. 
35. Donigan KA, Hile SE, Eckert KA, Sweasy
JB. The human gastric cancer-associated
DNA polymerase beta variant D160N is a
mutator that induces cellular transformation.
DNA Repair (Amst). 2012;11(4):381-90. 
36. Dalal S, Hile S, Eckert KA, Sun KW, Starce-
vic D, Sweasy JB. Prostate-cancer-associated
I260M variant of DNA polymerase beta is a
sequence-specific mutator. Biochemistry.
2005;44(48):15664-73. 
37. Donigan KA, Tuck D, Schulz V, Sweasy JB.
DNA polymerase beta variant Ile260Met
generates global gene expression changes re-
lated to cellular transformation. Mutagenesis.
2012;27(6):683-91. 
38. Ehmsen KT, Heyer WD. Biochemistry of
Meiotic Recombination: Formation, Process-
ing, and Resolution of Recombination Inter-
mediates. Genome Dyn Stab. 2008;3:91. 
39. Keeney S. Spo11 and the Formation of DNA
Double-Strand Breaks in Meiosis. Genome
Dyn Stab. 2008;2:81-123. 
40. Roeder GS. Meiotic chromosomes: it takes two
to tango. Genes Dev. 1997;11(20):2600-21. 
41. Kidane D, Jonason AS, Gorton TS, Mihaylov
I, Pan J, Keeney S, et al. DNA polymerase
beta is critical for mouse meiotic synapsis.
EMBO J. 2010;29(2):410-23.
42. Cohen PE, Pollard JW. Regulation of meiotic
recombination and prophase I progression in
mammals. Bioessays. 2001;23(11):996-1009.
43. Phadnis N, Hyppa RW, Smith GR. New and
old ways to control meiotic recombination.
Trends Genet. 2011;27(10):411-21. 
44. Plug AW, Clairmont CA, Sapi E, Ashley T,
Sweasy JB. Evidence for a role for DNA
polymerase beta in mammalian meiosis. Proc
Natl Acad Sci USA. 1997;94(4):1327-31. 
45. Canitrot Y, Capp JP, Puget N, Bieth A, Lopez
B, Hoffmann JS, et al. DNA polymerase beta
overexpression stimulates the Rad51-dependent
homologous recombination in mammalian
cells. Nucleic Acids Res. 2004;32(17):5104-12. 
469Ray et al.: Cellular roles of DNA polymerase beta
